| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AACR/IARC meeting on carcinogenesis from environmental pollution: Assessment of human risk and strategies for prevention*
|
Jones, S.
|
|
|
8 |
2 |
p. 137-138
|
artikel
|
| 2 |
AACR/IARC meeting on carcinogenesis from environmental pollution:Assessment of human risk and strategies for prevention
|
S. Jones
|
|
1997
|
8 |
2 |
p. 137-138
2 p.
|
artikel
|
| 3 |
Analysis of the cyclin-dependent kinase inhibitors p18 and p19 inmantle-cell lymphoma and chronic lymphocytic leukemia
|
M. E. Williams
|
|
1997
|
8 |
2 |
p. 71-73
3 p.
|
artikel
|
| 4 |
Asia on the move
|
|
|
|
8 |
2 |
p. 101
|
artikel
|
| 5 |
Awards, appointments
|
|
|
|
8 |
2 |
p. 103
|
artikel
|
| 6 |
Bcl-1/cyclin D1 in malignant lymphoma
|
C. J. de Boer
|
|
1997
|
8 |
2 |
p. 109-117
9 p.
|
artikel
|
| 7 |
Bcl-6 protein expression in normal and neoplastic lymphoidtissues
|
B. Falini
|
|
1997
|
8 |
2 |
p. 101-104
4 p.
|
artikel
|
| 8 |
BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease
|
Diehl, V.
|
|
|
8 |
2 |
p. 143-148
|
artikel
|
| 9 |
BEACOPP: An intensified chemotherapy regimen in advanced Hodgkinsdisease
|
V. Diehl
|
|
1997
|
8 |
2 |
p. 143-148
6 p.
|
artikel
|
| 10 |
Book review
|
Boyle, P.
|
|
|
8 |
2 |
p. 108
|
artikel
|
| 11 |
Book review
|
Armitage, J.O.
|
|
|
8 |
2 |
p. 206
|
artikel
|
| 12 |
Bookreview
|
P. Boyle
|
|
1997
|
8 |
2 |
p. 108-108
1 p.
|
artikel
|
| 13 |
Cb/cc lymphoma: A distinct subtype of non-Hodgkins lymphoma?
|
L. Munksgaard
|
|
1997
|
8 |
2 |
p. 25-28
4 p.
|
artikel
|
| 14 |
Cd30-ligand and CD40-ligand expression in lymph nodes involved withHodgkins disease
|
A. Younes
|
|
1997
|
8 |
2 |
p. 97-100
4 p.
|
artikel
|
| 15 |
Changes suggested in Dutch system of reporting euthanasia and assistated suicide
|
|
|
|
8 |
2 |
p. 101-102
|
artikel
|
| 16 |
Changing trends in the incidence of non-Hodgkins lymphoma inEurope
|
G. Morgan
|
|
1997
|
8 |
2 |
p. 49-54
6 p.
|
artikel
|
| 17 |
Characteristics of human EBV-specific cytotoxic T lymphocytes utilizedfor adoptive immunotherapy of EBV-induced lymphoproliferations in xenograftedSCID mice
|
J. F. Lacerda
|
|
1997
|
8 |
2 |
p. 137-140
4 p.
|
artikel
|
| 18 |
Classification of T-cell and NK-cell neoplasms based on the REALclassification
|
E. S. Jaffe
|
|
1997
|
8 |
2 |
p. 17-24
8 p.
|
artikel
|
| 19 |
Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere)
|
Hilkens, P.H. E.
|
|
|
8 |
2 |
p. 187-190
|
artikel
|
| 20 |
Clinical characteristics of severe peripheral neuropathy induced bydocetaxel (Taxotere)
|
P. H. E. Hilkens
|
|
1997
|
8 |
2 |
p. 187-190
4 p.
|
artikel
|
| 21 |
Contents of the next issue
|
|
|
|
8 |
2 |
p. vi
|
artikel
|
| 22 |
Copyright
|
|
|
|
8 |
2 |
p. iv
|
artikel
|
| 23 |
Corrigendum
|
Colombo, T.
|
|
|
8 |
2 |
p. 207
|
artikel
|
| 24 |
Detection of trisomy 12 in CD34+ progenitor cells in a patient withB-cell chronic lymphocytic leukemia by fluorescence in situhybridization
|
B. Gahn
|
|
1997
|
8 |
2 |
p. 55-57
3 p.
|
artikel
|
| 25 |
Docetaxel and interstitial pulmonary injury
|
Merad, M.
|
|
|
8 |
2 |
p. 191-194
|
artikel
|
| 26 |
Docetaxel and interstitial pulmonary injury
|
M. Merad
|
|
1997
|
8 |
2 |
p. 191-194
4 p.
|
artikel
|
| 27 |
Dose intensity in patients with metastatic breast cancer - time for novel thoughts?
|
Bergh, J.
|
|
|
8 |
2 |
p. 109-110
|
artikel
|
| 28 |
Dose intensity in patients with metastatic breast cancer ^ time for novelthoughts?
|
J. Bergh
|
|
1997
|
8 |
2 |
p. 109-110
2 p.
|
artikel
|
| 29 |
Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer*
|
Brufman, G.
|
|
|
8 |
2 |
p. 155-162
|
artikel
|
| 30 |
Doubling epirubicin dose intensity (100 mg/m^2versus 50 mg/m^2) in the FEC regimen significantly increasesresponse rates. An international randomised phase III study in metastaticbreast cancer
|
G. Brufman
|
|
1997
|
8 |
2 |
p. 155-162
8 p.
|
artikel
|
| 31 |
Editorial board
|
|
|
|
8 |
2 |
p. v
|
artikel
|
| 32 |
Etoposide, intermediate-dose cytarabine and carboplatin (VAC): A combination therapy for the blastic phase of chronic myelogenous leukemia
|
Montefusco, E.
|
|
|
8 |
2 |
p. 175-179
|
artikel
|
| 33 |
Etoposide, intermediate-dose cytarabine and carboplatin (VAC): Acombination therapy for the blastic phase of chronic myelogenousleukemia
|
E. Montefusco
|
|
1997
|
8 |
2 |
p. 175-179
5 p.
|
artikel
|
| 34 |
5-Fluorouracil-based treatment of patients with advanced colorectal carcinoma outside clinical trials: Importance of limited toxicity
|
Halteren, H.K. van
|
|
|
8 |
2 |
p. 203
|
artikel
|
| 35 |
5-Fluorouracil revisited: A new perspective for treatment planning
|
Presant, C.A.
|
|
|
8 |
2 |
p. 203-204
|
artikel
|
| 36 |
Helicobacter pylori eradication for the treatment of low-gradegastric MALT lymphoma: Follow-up together with sequential molecularstudies
|
C. Montalban
|
|
1997
|
8 |
2 |
p. 37-39
3 p.
|
artikel
|
| 37 |
High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study
|
Labianca, R.
|
|
|
8 |
2 |
p. 169-174
|
artikel
|
| 38 |
High- versus low-dose levo-leucovorin as a modulator of5-fluorouracil in advanced colorectal cancer: A GISCAD phase III study
|
R. Labianca
|
|
1997
|
8 |
2 |
p. 169-174
6 p.
|
artikel
|
| 39 |
Ifosfamide and paclitaxel salvage chemotherapy for advanced epithelial ovarian cancer
|
Dimopoulos, M.A.
|
|
|
8 |
2 |
p. 195-197
|
artikel
|
| 40 |
Ifosfamide and paclitaxel salvage chemotherapy for advanced epithelialovarian cancer
|
M. A. Dimopoulos
|
|
1997
|
8 |
2 |
p. 195-197
3 p.
|
artikel
|
| 41 |
Infusional 5-fluorouracil in the treatment of gastrointestinal cancers: The Royal Marsden Hospital experience
|
Ross, P.J.
|
|
|
8 |
2 |
p. 111-115
|
artikel
|
| 42 |
Infusional 5-fluorouracil in the treatment of gastrointestinal cancers:The Royal Marsden Hospital experience
|
P. J. Ross
|
|
1997
|
8 |
2 |
p. 111-115
5 p.
|
artikel
|
| 43 |
Integration of EpsteinBarr virus in Burkitts lymphoma cells leadsto a region of enhanced chromosome instability
|
A. Jox
|
|
1997
|
8 |
2 |
p. 131-135
5 p.
|
artikel
|
| 44 |
In this Issue
|
|
|
|
8 |
2 |
p. vi
|
artikel
|
| 45 |
Involvement of the bcl-6 gene in AIDS-related lymphomas
|
G. Gaidano
|
|
1997
|
8 |
2 |
p. 105-108
4 p.
|
artikel
|
| 46 |
Labour vows to change the NHS
|
|
|
|
8 |
2 |
p. 102-103
|
artikel
|
| 47 |
L-asparagine-depletion: Another opinion
|
Baumgart, J.
|
|
|
8 |
2 |
p. 204
|
artikel
|
| 48 |
Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) inanaplastic large-cell lymphoma, but not in other non-Hodgkins lymphomas,Hodgkins disease, or lymphomatoid papulosis
|
A. H. Sarris
|
|
1997
|
8 |
2 |
p. 59-63
5 p.
|
artikel
|
| 49 |
Management of secretions in esophageal cancer patients with glycopyrrolate
|
Rashid, H.
|
|
|
8 |
2 |
p. 198-199
|
artikel
|
| 50 |
Management of secretions in esophageal cancer patients withglycopyrrolate
|
H. Rashid
|
|
1997
|
8 |
2 |
p. 198-199
2 p.
|
artikel
|
| 51 |
New knowledge about T-cell cytotoxicity
|
J.-C. Cerottini
|
|
1997
|
8 |
2 |
p. 75-78
4 p.
|
artikel
|
| 52 |
Normal and malignant B-cell development with special reference toHodgkins disease
|
K. Rajewsky
|
|
1997
|
8 |
2 |
p. 79-81
3 p.
|
artikel
|
| 53 |
Npm/alk fusion mRNA expression in Hodgkin and ReedSternberg cellsis rare but does occur: Results from single-cell cDNA analysis
|
L. Trümper
|
|
1997
|
8 |
2 |
p. 83-87
5 p.
|
artikel
|
| 54 |
Pathogenesis of gastric lymphoma: The enigma in Hong Kong
|
W. S. Xu
|
|
1997
|
8 |
2 |
p. 41-44
4 p.
|
artikel
|
| 55 |
Perhaps not everyone knows that…
|
|
|
|
8 |
2 |
p. 103-104
|
artikel
|
| 56 |
Primary B-cell lymphomas of the skin
|
H. Kerl
|
|
1997
|
8 |
2 |
p. 29-32
4 p.
|
artikel
|
| 57 |
Principles of the revised EuropeanAmerican lymphoma classification(from the International Lymphoma Study Group)
|
N. L. Harris
|
|
1997
|
8 |
2 |
p. 11-16
6 p.
|
artikel
|
| 58 |
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer
|
Glimelius, B.
|
|
|
8 |
2 |
p. 163-168
|
artikel
|
| 59 |
Randomized comparison between chemotherapy plus best supportive care withbest supportive care in advanced gastric cancer
|
B. Glimelius
|
|
1997
|
8 |
2 |
p. 163-168
6 p.
|
artikel
|
| 60 |
Reply from the author
|
Herrmann, R.
|
|
|
8 |
2 |
p. 141
|
artikel
|
| 61 |
Role of interferon as a modulator of fluoropyrimidines: Reply to a recent editorial
|
Wadler, S.
|
|
|
8 |
2 |
p. 139-140
|
artikel
|
| 62 |
Role of interferon as a modulator of fluoropyrimidines: Reply to a recenteditorial
|
S. Wadler
|
|
1997
|
8 |
2 |
p. 139-140
2 p.
|
artikel
|
| 63 |
Sexual dysfunction in treated breast cancer patients
|
Barni, S.
|
|
|
8 |
2 |
p. 149-153
|
artikel
|
| 64 |
Sexual dysfunction in treated breast cancer patients
|
S. Barni
|
|
1997
|
8 |
2 |
p. 149-153
5 p.
|
artikel
|
| 65 |
Sexual functioning after breast cancer: A conceptual framework for future studies
|
Ganz, P.A.
|
|
|
8 |
2 |
p. 105-107
|
artikel
|
| 66 |
Sexual functioning after breast cancer: A conceptual frameworkfor future studies
|
P.A. Ganz
|
|
1997
|
8 |
2 |
p. 105-107
3 p.
|
artikel
|
| 67 |
Somatic mutations of the translocated bcl-2 gene are associatedwith morphologic transformation of follicular lymphoma to diffuse large-celllymphoma
|
A. Matolcsy
|
|
1997
|
8 |
2 |
p. 119-122
4 p.
|
artikel
|
| 68 |
Specific detection of Helicobacter pylori and nonHelicobacterpylori flora in small- and large-cell primary gastric B-cellnon-hodgkins lymphoma
|
I. A. M. Gisbertz
|
|
1997
|
8 |
2 |
p. 33-36
4 p.
|
artikel
|
| 69 |
Table of Contents
|
|
|
|
8 |
2 |
p. iii-iv
|
artikel
|
| 70 |
The Kaposis sarcomaassociated herpes virus (human herpesvirus-8)in Kaposis sarcoma, malignant lymphoma, and other diseases
|
D. M. Knowles
|
|
1997
|
8 |
2 |
p. 123-129
7 p.
|
artikel
|
| 71 |
The problem of classifying lymphomas: An orderly prescription forprogress
|
C. W. Berard
|
|
1997
|
8 |
2 |
p. 3-9
7 p.
|
artikel
|
| 72 |
The role of eosinophils in the pathobiology of Hodgkins disease
|
A. Pinto
|
|
1997
|
8 |
2 |
p. 89-96
8 p.
|
artikel
|
| 73 |
The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy
|
Pater, J.L.
|
|
|
8 |
2 |
p. 181-185
|
artikel
|
| 74 |
The role of the 5-HT_3 antagonists ondansetron anddolasetron in the control of delayed onset nausea and vomiting in patientsreceiving moderately emetogenic chemotherapy
|
J. L. Pater
|
|
1997
|
8 |
2 |
p. 181-185
5 p.
|
artikel
|
| 75 |
The Sixth Lugano Conference: Basic Science Papers
|
S.T. Ong
|
|
1997
|
8 |
2 |
p. 1-2
2 p.
|
artikel
|
| 76 |
The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patients
|
Burger, J.A.
|
|
|
8 |
2 |
p. 200-202
|
artikel
|
| 77 |
The transjugular stent implantation for the treatment of malignant portaland hepatic vein obstruction in cancer patients
|
J. A. Burger
|
|
1997
|
8 |
2 |
p. 200-202
3 p.
|
artikel
|
| 78 |
The use of fluorescent in situ hybridization for detection of thet(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma
|
P. W. M. Johnson
|
|
1997
|
8 |
2 |
p. 65-69
5 p.
|
artikel
|
| 79 |
This letter was referred to the authors, who respond as follows:
|
Rizzari, C.
|
|
|
8 |
2 |
p. 205-206
|
artikel
|
| 80 |
Trans-rearrangements and the risk of lymphoid malignancy
|
I. R. Kirsch
|
|
1997
|
8 |
2 |
p. 45-48
4 p.
|
artikel
|
| 81 |
Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
|
Simonetti, R.G.
|
|
|
8 |
2 |
p. 117-136
|
artikel
|
| 82 |
Treatment of hepatocellular carcinoma: A systematic review of randomizedcontrolled trials
|
R. G. Simonetti
|
|
1997
|
8 |
2 |
p. 117-136
20 p.
|
artikel
|
Tijdschrift beschrijving